These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7555469)

  • 1. Muscle sympathetic nerve activity is higher in intensively versus conventionally treated IDDM subjects.
    Hoffman RP; Sinkey CA; Anderson EA
    Diabetes Care; 1995 Mar; 18(3):287-91. PubMed ID: 7555469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemia increases muscle sympathetic nerve activity in IDDM and control subjects.
    Hoffman RP; Sinkey CA; Anderson EA
    Diabetes Care; 1994 Jul; 17(7):673-80. PubMed ID: 7924776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle sympathetic nerve activity is reduced in IDDM before overt autonomic neuropathy.
    Hoffman RP; Sinkey CA; Kienzle MG; Anderson EA
    Diabetes; 1993 Mar; 42(3):375-80. PubMed ID: 8432407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of relationship between muscle sympathetic nerve activity and skeletal muscle vasodilation in response to insulin infusion.
    Spraul M; Ravussin E; Baron AD
    Diabetologia; 1996 Jan; 39(1):91-6. PubMed ID: 8720608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM.
    Maran A; Lomas J; Macdonald IA; Amiel SA
    Diabetologia; 1995 Dec; 38(12):1412-8. PubMed ID: 8786014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.
    Torlone E; Britta M; Rambotti AM; Perriello G; Santeusanio F; Brunetti P; Bolli GB
    Diabetes Care; 1993 Oct; 16(10):1347-55. PubMed ID: 8269792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneurographically determined muscle sympathetic nerve activity levels are reproducible in insulin-dependent diabetes mellitus.
    Hoffman RP; Sinkey CA; Anderson EA
    J Diabetes Complications; 1998; 12(6):307-10. PubMed ID: 9877463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.
    Melki V; Renard E; Lassmann-Vague V; Boivin S; Guerci B; Hanaire-Broutin H; Bringer J; Belicar P; Jeandidier N; Meyer L; Blin P; Augendre-Ferrante B; Tauber JP
    Diabetes Care; 1998 Jun; 21(6):977-82. PubMed ID: 9614617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to neuroglycopenia: an adaptive response during intensive insulin treatment of diabetes.
    Jones TW; Borg WP; Borg MA; Boulware SD; McCarthy G; Silver D; Tamborlane WV; Sherwin RS
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1713-8. PubMed ID: 9177369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine metabolism in IDDM. Role of insulin and substrate availability.
    Luzi L; Castellino P; Simonson DC; Petrides AS; DeFronzo RA
    Diabetes; 1990 Jan; 39(1):38-48. PubMed ID: 2210059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucine kinetics during a brief fast in diabetes in pregnancy.
    Kalhan SC; Denne SC; Patel DM; Nuamah IF; Savin SM
    Metabolism; 1994 Mar; 43(3):378-84. PubMed ID: 8139488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterregulatory hormone responses after long-term continuous subcutaneous insulin infusion with lispro insulin.
    Tsui EY; Chiasson JL; Tildesley H; Barnie A; Simkins S; Strack T; Zinman B
    Diabetes Care; 1998 Jan; 21(1):93-6. PubMed ID: 9538976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glycemic control on the growth velocity and several metabolic parameters of conventionally treated children with insulin dependent diabetes mellitus.
    Gunczler P; Lanes R; Esaa S; Paoli M
    J Pediatr Endocrinol Metab; 1996; 9(6):569-75. PubMed ID: 9004171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic control and peripheral nerve conduction in children and young adults after 5-6 mo of IDDM. Wisconsin Diabetes Registry.
    Allen C; Duck SC; Sufit RL; Swick HM; D'Alessio DJ
    Diabetes Care; 1992 Apr; 15(4):502-7. PubMed ID: 1499465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary C-peptide as an index of unstable glycemic control in insulin-dependent diabetes mellitus (IDDM).
    Cha T; Tahara Y; Ikegami H; Fukuda M; Yoneda H; Yamato E; Yamamoto Y; Noma Y; Shima K; Ogihara T
    Diabetes Res Clin Pract; 1991 Sep; 13(3):181-7. PubMed ID: 1959481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No deleterious effects of tight blood glucose control on 24-hour ambulatory blood pressure in normoalbuminuric insulin-dependent diabetes mellitus patients.
    Poulsen PL; Hansen KW; Ebbehøj E; Knudsen ST; Mogensen CE
    J Clin Endocrinol Metab; 2000 Jan; 85(1):155-8. PubMed ID: 10634379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemic symptom variation is related to epinephrine and not peripheral muscle sympathetic nerve response.
    Hoffman RP; Sinkey CA; Anderson EA
    J Diabetes Complications; 1997; 11(1):15-20. PubMed ID: 9025008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.
    Dagogo-Jack SE; Craft S; Cryer PE
    J Clin Invest; 1993 Mar; 91(3):819-28. PubMed ID: 8450063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM.
    Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Di Vincenzo A; Modarelli F; Ciofetta M; Lepore M; Annibale B; Torlone E
    Diabetologia; 1994 Dec; 37(12):1265-76. PubMed ID: 7895957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.